LDLR and atherosclerosis: Recent data in rodent models and humans indicate that it is induced in insulin-sensitive tissues during aging and it mediates insulin receptor-β cleavage to promote insulin resistance and low-density lipoprotein receptor (LDLR) cleavage to accelerate atherosclerosis in apoE-null mice (2, 5, 6).